Production (Stage)
Tonix Pharmaceuticals Holding Corp.
TNXP
$28.93
$2.539.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.88% | -55.55% | 81.96% | -427.32% | 45.32% |
| Total Depreciation and Amortization | -49.28% | 90.59% | -47.26% | -4.26% | -32.62% |
| Total Amortization of Deferred Charges | 123.55% | -232.06% | -43.05% | -26.89% | 310.92% |
| Total Other Non-Cash Items | 712.57% | -72.23% | -97.90% | 1,280.20% | -258.22% |
| Change in Net Operating Assets | -151.15% | 196.85% | -237.48% | 313.65% | 220.94% |
| Cash from Operations | -13.32% | 22.18% | -89.55% | 43.56% | 21.33% |
| Capital Expenditure | -100.00% | 66.67% | -- | 100.00% | 75.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | 66.67% | -- | 100.00% | 74.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,268.79% | 0.00% | 0.00% | -200.00% | -- |
| Issuance of Common Stock | -27.65% | 94.46% | 268.73% | 53,960.87% | -99.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31.13% | -47.27% | 52.42% | -- | -- |
| Cash from Financing | -41.83% | 98.47% | 510.75% | 3,413.68% | -100.52% |
| Foreign Exchange rate Adjustments | -137.50% | 241.18% | -1,800.00% | 125.00% | 60.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.31% | 192.99% | 932.28% | 83.84% | -199.81% |